{"transactions":[{"id":937106,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":69242,"kind":"person","name":"Adawi Kamal","position":1,"cik":"0001788393","reported_name":"Adawi Kamal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-16T21:02:16.000Z","date":"2026-01-15","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest in 36 equal monthly installments following January 1, 2026, such that all of the shares shall be fully vested and exercisable on January 1, 2029, subject to the Reporting Person's continued service with the Issuer as of each such vesting date."}],"balance_after":75000,"derivative":{"exercise_price":1.05,"expiration_date":"2036-01-14","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001193125-26-015323","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000119312526015323/ownership.xml","form_type":"4"}},{"id":937105,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":69242,"kind":"person","name":"Adawi Kamal","position":1,"cik":"0001788393","reported_name":"Adawi Kamal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-16T21:02:16.000Z","date":"2026-01-15","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of restricted stock units (\"RSUs\") that vest with respect to 1/4th of the RSUs on each of January 8, 2027, January 8, 2028, January 8, 2029 and January 8, 2030, subject to the Reporting Person's continued service with the Issuer as of each such vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement."}],"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001193125-26-015323","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000119312526015323/ownership.xml","form_type":"4"}},{"id":1015228,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":69242,"kind":"person","name":"Adawi Kamal","position":1,"cik":"0001788393","reported_name":"Adawi Kamal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-21T20:08:42.000Z","date":"2025-10-20","kind":"grant","planned":false,"acquired":true,"shares":375000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest as to 25% of the underlying shares on October 20, 2026 and thereafter on a monthly basis for 36 additional months, subject to the Reporting Person's continuous service to the Issuer as of each such vesting date."}],"balance_after":375000,"derivative":{"exercise_price":1.54,"expiration_date":"2035-10-20","underlying":"Common Stock","underlying_shares":375000},"source":{"system":"sec-edgar","filing":"0001193125-25-245106","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000119312525245106/ownership.xml","form_type":"4"}},{"id":1015227,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":69242,"kind":"person","name":"Adawi Kamal","position":1,"cik":"0001788393","reported_name":"Adawi Kamal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-10-21T20:08:42.000Z","date":"2025-10-20","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Award of restricted stock units that vest with respect to 1/4th of the underlying shares on each of November 1, 2026, November 1, 2027, November 1, 2028, and November 1, 2029, subject to the Reporting Person's continued service with the Issuer as of each such vesting date."}],"balance_after":75000,"source":{"system":"sec-edgar","filing":"0001193125-25-245106","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000119312525245106/ownership.xml","form_type":"4"}},{"id":1591179,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":69242,"kind":"person","name":"Adawi Kamal","position":1,"cik":"0001788393","reported_name":"Adawi Kamal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Corporate Secretary"}}],"security":"Common Stock","published_at":"2024-03-06T21:05:23.000Z","date":"2024-03-04","kind":"sale","planned":false,"acquired":false,"shares":3487,"price":1.9099,"value":6659.8213,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2021."}],"balance_after":243749,"source":{"system":"sec-edgar","filing":"0001274737-24-000017","document":"wk-form4_1709759110.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1274737/000127473724000017/wk-form4_1709759110.xml","form_type":"4"}},{"id":1591178,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":69242,"kind":"person","name":"Adawi Kamal","position":1,"cik":"0001788393","reported_name":"Adawi Kamal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Corporate Secretary"}}],"security":"Common Stock","published_at":"2024-03-06T21:05:23.000Z","date":"2024-03-04","kind":"sale","planned":false,"acquired":false,"shares":9297,"price":1.9089,"value":17747.0433,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on March 1, 2023."}],"balance_after":247236,"source":{"system":"sec-edgar","filing":"0001274737-24-000017","document":"wk-form4_1709759110.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274737/000127473724000017/wk-form4_1709759110.xml","form_type":"4"}},{"id":1625053,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":69242,"kind":"person","name":"Adawi Kamal","position":1,"cik":"0001788393","reported_name":"Adawi Kamal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Corporate Secretary"}}],"security":"Common Stock","published_at":"2024-02-22T21:11:55.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 75,000 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units will vest with respect to 25% of the restricted stock units on each of the first, second, third and fourth anniversaries of March 1, 2024, subject to the Reporting Person's continued service through the applicable vesting date. In addition, the award may become fully vested upon a qualifying termination of employment in accordance with the Company's Amended and Restated Executive Change in Control Severance Plan, as the same may be amended from time to time."}],"balance_after":256533,"source":{"system":"sec-edgar","filing":"0001274737-24-000013","document":"wk-form4_1708636280.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274737/000127473724000013/wk-form4_1708636280.xml","form_type":"4"}},{"id":1653218,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":69242,"kind":"person","name":"Adawi Kamal","position":1,"cik":"0001788393","reported_name":"Adawi Kamal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Corporate Secretary"}}],"security":"Common Stock","published_at":"2024-02-08T21:05:31.000Z","date":"2024-02-06","kind":"sale","planned":false,"acquired":false,"shares":6738,"price":1.9491,"value":13133.0358,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on February 4, 2022."}],"balance_after":181533,"source":{"system":"sec-edgar","filing":"0001274737-24-000009","document":"wk-form4_1707426312.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274737/000127473724000009/wk-form4_1707426312.xml","form_type":"4"}},{"id":1972569,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":69242,"kind":"person","name":"Adawi Kamal","position":1,"cik":"0001788393","reported_name":"Adawi Kamal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Corporate Secretary"}}],"security":"Common Stock","published_at":"2023-03-03T21:38:11.000Z","date":"2023-03-02","kind":"sale","acquired":false,"shares":3667,"price":2.2993,"value":8431.5331,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2021."}],"balance_after":188271,"source":{"system":"sec-edgar","filing":"0001274737-23-000014","document":"wf-form4_167787945297244.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274737/000127473723000014/wf-form4_167787945297244.xml","form_type":"4"}},{"id":1983302,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":69242,"kind":"person","name":"Adawi Kamal","position":1,"cik":"0001788393","reported_name":"Adawi Kamal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Corporate Secretary"}}],"security":"Common Stock","published_at":"2023-03-01T21:06:54.000Z","date":"2023-02-27","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 100,000 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units will vest with respect to 25% of the restricted stock units on each of the first, second, third and fourth anniversaries of March 1, 2023, subject to the Reporting Person's continued service through the applicable vesting date. In addition, the award may become fully vested upon a qualifying termination of employment in accordance with the Company's Amended and Restated Executive Change in Control Severance Plan, as the same may be amended from time to time."}],"balance_after":191938,"source":{"system":"sec-edgar","filing":"0001274737-23-000012","document":"wf-form4_167770478495929.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274737/000127473723000012/wf-form4_167770478495929.xml","form_type":"4"}},{"id":2022435,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":69242,"kind":"person","name":"Adawi Kamal","position":1,"cik":"0001788393","reported_name":"Adawi Kamal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Corporate Secretary"}}],"security":"Common Stock","published_at":"2023-02-10T21:05:30.000Z","date":"2023-02-08","kind":"sale","acquired":false,"shares":5821,"price":2.6921,"value":15670.7141,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on February 4, 2022."}],"balance_after":91938,"source":{"system":"sec-edgar","filing":"0001274737-23-000007","document":"wf-form4_167606311295012.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274737/000127473723000007/wf-form4_167606311295012.xml","form_type":"4"}},{"id":2360063,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":69242,"kind":"person","name":"Adawi Kamal","position":1,"cik":"0001788393","reported_name":"Adawi Kamal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Corporate Secretary"}}],"security":"Common Stock","published_at":"2022-03-02T21:39:00.000Z","date":"2022-03-01","kind":"tax_withholding","acquired":false,"shares":3241,"price":7.12,"value":23075.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were withheld from the Reporting Person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted on February 23, 2021."}],"balance_after":97759,"source":{"system":"sec-edgar","filing":"0001274737-22-000017","document":"wf-form4_164625710800777.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274737/000127473722000017/wf-form4_164625710800777.xml","form_type":"4"}},{"id":2408058,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":69242,"kind":"person","name":"Adawi Kamal","position":1,"cik":"0001788393","reported_name":"Adawi Kamal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Corporate Secretary"}}],"security":"Common Stock","published_at":"2022-02-08T21:20:47.000Z","date":"2022-02-04","kind":"grant","acquired":true,"shares":63500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 63,500 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock unit will vest with respect to 25% of the restricted stock units on each of the first, second, third and fourth anniversaries of February 4, 2022, subject to the Reporting Person's continued service through the applicable vesting date. In addition, the award may become fully vested upon a qualifying termination of employment in connection with a change in control."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents 63,500 shares of restricted stock units granted on February 4, 2022 and 37,500 shares of restricted stock units granted on February 23, 2021."}],"balance_after":101000,"source":{"system":"sec-edgar","filing":"0001274737-22-000009","document":"wf-form4_164435521542460.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274737/000127473722000009/wf-form4_164435521542460.xml","form_type":"4"}},{"id":2832302,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":69242,"kind":"person","name":"Adawi Kamal","position":1,"cik":"0001788393","reported_name":"Adawi Kamal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option(right to buy)","published_at":"2021-02-25T22:05:45.000Z","date":"2021-02-23","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option is exercisable as it vests. 25% of the shares subject to the option vest on February 23, 2022, and 1/48th of the total number of shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date. In addition, the stock option may become fully vested upon a qualifying termination of employment in connection with a change in control."}],"balance_after":12500,"derivative":{"exercise_price":18.2,"expiration_date":"2031-02-22","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001274737-21-000010","document":"wf-form4_161429071161279.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1274737/000127473721000010/wf-form4_161429071161279.xml","form_type":"4"}},{"id":2832301,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":69242,"kind":"person","name":"Adawi Kamal","position":1,"cik":"0001788393","reported_name":"Adawi Kamal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-02-25T22:05:45.000Z","date":"2021-02-23","kind":"grant","acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units will vest with respect to 25% of the restricted stock units on each of the first, second, third and fourth anniversaries of March 1, 2020, subject to the Reporting Person's continued service through the applicable vesting date. In addition, the award may become fully vested upon a qualifying termination of employment in connection with a change in control."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents 37,500 shares of restricted stock units."}],"balance_after":37500,"source":{"system":"sec-edgar","filing":"0001274737-21-000010","document":"wf-form4_161429071161279.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274737/000127473721000010/wf-form4_161429071161279.xml","form_type":"4"}},{"id":3314416,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":69242,"kind":"person","name":"Adawi Kamal","position":1,"cik":"0001788393","reported_name":"Adawi Kamal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option(right to buy)","published_at":"2020-01-09T22:08:13.000Z","date":"2020-01-09","kind":"grant","acquired":true,"shares":52500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is exercisable as it vests. 25% of the shares subject to the option vest on January 1, 2021, and 1/48th of the total number of shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":52500,"derivative":{"exercise_price":24.19,"expiration_date":"2030-01-08","underlying":"Stock Option(right to buy)","underlying_shares":52500},"source":{"system":"sec-edgar","filing":"0001274737-20-000012","document":"wf-form4_157860767626977.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274737/000127473720000012/wf-form4_157860767626977.xml","form_type":"4"}},{"id":3408862,"issuer":{"id":935,"kind":"organization","name":"EXAGEN INC.","symbol":"XGN"},"owners":[{"id":69242,"kind":"person","name":"Adawi Kamal","position":1,"cik":"0001788393","reported_name":"Adawi Kamal","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-09-20T22:58:39.000Z","date":"2019-09-18","kind":"grant","acquired":true,"shares":21635,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is exercisable as it vests. 25% of the shares subject to the option vest on September 18, 2020, and 1/48th of the total number of shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date."}],"balance_after":21635,"derivative":{"exercise_price":14,"expiration_date":"2029-09-17","underlying":"Common Stock","underlying_shares":21635},"source":{"system":"sec-edgar","filing":"0000899243-19-024016","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274737/000089924319024016/doc4.xml","form_type":"4"}}]}